148 related articles for article (PubMed ID: 18696068)
21. An evaluation of the procoagulant action of recombinant activated factor VII in cord whole blood versus adult whole blood using thromboelastography.
Koestenberger M; Gallistl S; Muntean W; Ferstl U; Kutschera J; Cvirn G
Blood Coagul Fibrinolysis; 2005 Nov; 16(8):613-7. PubMed ID: 16269937
[TBL] [Abstract][Full Text] [Related]
22. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
Dickneite G; Dörr B; Kaspereit F; Tanaka KA
J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
[TBL] [Abstract][Full Text] [Related]
23. Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro.
Darlington DN; Delgado AV; Kheirabadi BS; Fedyk CG; Scherer MR; Pusateri AE; Wade CE; Cap AP; Holcomb JB; Dubick MA
J Trauma; 2011 Nov; 71(5):1152-63. PubMed ID: 21610535
[TBL] [Abstract][Full Text] [Related]
24. Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates.
Winstedt D; Tynngård N; Olanders K; Schött U
Scand J Trauma Resusc Emerg Med; 2013 Mar; 21():20. PubMed ID: 23517637
[TBL] [Abstract][Full Text] [Related]
25. Monitoring recombinant factor VIIa treatment: efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy.
Ganter MT; Schmuck S; Hamiel CR; Wischmeyer PE; Heule D; Zollinger A; Hofer CK
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):675-80. PubMed ID: 18922422
[TBL] [Abstract][Full Text] [Related]
26. Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates.
Caballo C; Escolar G; Diaz-Ricart M; Lopez-Vílchez I; Lozano M; Cid J; Pino M; Beltrán J; Basora M; Pereira A; Galan AM
Blood Transfus; 2013 Jul; 11(3):391-9. PubMed ID: 23058866
[TBL] [Abstract][Full Text] [Related]
27. [Thrombelastographic coagulation analysis following in vitro and in vivo haemodilution with hydroxyethyl starch (HES)].
Asskali F; Lehmann G; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 May; 37(5):258-66. PubMed ID: 12015682
[TBL] [Abstract][Full Text] [Related]
28. Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven).
Viuff D; Lauritzen B; Pusateri AE; Andersen S; Rojkjaer R; Johansson PI
Br J Anaesth; 2008 Sep; 101(3):324-31. PubMed ID: 18565966
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy.
Fenger-Eriksen C; Tønnesen E; Ingerslev J; Sørensen B
J Thromb Haemost; 2009 Jul; 7(7):1099-105. PubMed ID: 19422451
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the overall haemostatic effect of recombinant factor VIIa by measuring thrombin generation and stability of fibrin clots.
Dargaud Y; Prevost C; Lienhart A; Claude Bordet J; Negrier C
Haemophilia; 2011 Nov; 17(6):957-61. PubMed ID: 21453422
[TBL] [Abstract][Full Text] [Related]
31. Variability of thromboelastographic responses following the administration of rFVIIa to haemophilia A dogs supports the individualization of therapy with a global test of haemostasis.
Othman M; Powell S; Hopman WM; Lillicrap D
Haemophilia; 2010 Nov; 16(6):919-25. PubMed ID: 20609015
[TBL] [Abstract][Full Text] [Related]
32. Activity of recombinant factor VIIa under different conditions in vitro: effect of temperature, pH, and haemodilution.
Bladbjerg EM; Jespersen J
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):369-74. PubMed ID: 18600084
[TBL] [Abstract][Full Text] [Related]
33. The in vitro effect of recombinant factor VIIa on coated platelet formation and clot dynamics of stored platelet concentrates.
Svendsen MS; Kristensen AT; Bochsen L; Salado-Jimena JA; Johansson PI
Transfusion; 2009 Oct; 49(10):2186-94. PubMed ID: 19527478
[TBL] [Abstract][Full Text] [Related]
34. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography.
Sørensen B; Ingerslev J
Haemophilia; 2005 Nov; 11 Suppl 1():1-6. PubMed ID: 16219042
[TBL] [Abstract][Full Text] [Related]
35. Low dose of hydroxyethyl starch impairs clot formation as assessed by viscoelastic devices.
Tynngård N; Berlin G; Samuelsson A; Berg S
Scand J Clin Lab Invest; 2014 Jun; 74(4):344-50. PubMed ID: 24621204
[TBL] [Abstract][Full Text] [Related]
36. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model.
Fries D; Innerhofer P; Reif C; Streif W; Klingler A; Schobersberger W; Velik-Salchner C; Friesenecker B
Anesth Analg; 2006 Feb; 102(2):347-51. PubMed ID: 16428520
[TBL] [Abstract][Full Text] [Related]
37. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
38. Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion.
Carr ME; Martin EJ; Kuhn JG; Seremetis SV
Thromb Haemost; 2003 May; 89(5):803-11. PubMed ID: 12719776
[TBL] [Abstract][Full Text] [Related]
39. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA
Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927
[TBL] [Abstract][Full Text] [Related]
40. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
